New Search

If you are not happy with the results below please do another search

1122 search results for:

201

TherageniX awarded £995K grant to develop powdered gene therapy for bone regeneration

TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the company’s gene therapy in a powder, a non-viral gene delivery […]

203

Agilent Technologies sells Resolution Bioscience to Exact Sciences

Agilent Technologies will sell Resolution Bioscience to Exact Sciences, a leading provider of cancer screening and diagnostic tests. Financial terms of the agreement were not disclosed. Resolution Bioscience develops and commercializes next-generation sequencing-based precision oncology solutions. Agilent acquired the company in 2021.

204

SMi Systems secures UK patent for breakthrough single-molecule imaging technology

SMi Systems has secured a patent from the UK Intellectual Property Office (IPO) for the single-molecule imaging technologies that underpin its super-resolution multi-omic platform. The patented technology consists of highly specialised optics that allow SMi to view single molecules at unprecedented resolution. When combined with the company’s uniquely designed consumables and deep learning techniques, the […]

207

Take a 360° look at your medical biology practice at the JIB congress

Attend the Innovation Days in Biology (JIB) and stay connected to the scientific, technical, professional and organizational developments of medical biology. Medical biology is essential to the health of our fellow citizens, from diagnosis to treatment and follow-up, scientists are continually looking for innovation. There are many hot topics expected at the event in Paris […]

210

Immunohistochemical approaches for the molecular subtyping of bladder cancer

The subtyping of bladder cancers is a complicated business. It is, however, necessary as it has important implications for prognosis and therapeutic decisions. CLI caught up with Asst. Prof. Chelsea L. Jackson (University of Manitoba, Winnipeg, MB, Canada) and Prof. David Berman (Queen’s University, Kingston, ON, Canada) to find out more about how the current […]